This article needs additional citations for verification. (August 2022) |
This article includes a list of general references, but it lacks sufficient corresponding inline citations. (May 2010) |
Monogram Biosciences, Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA and is a subsidiary of LabCorp. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.
Formerly | ViroLogic Inc. |
---|---|
Company type | Subsidiary |
Nasdaq: MGRM | |
Industry | Biotechnology |
Headquarters | South San Francisco, California |
Products | PhenoSense, PhenoSense GT, Trofile, GeneSeq, VeraTag, HERmark |
Number of employees | 379 (2008) |
Parent | LabCorp |
Website | www |
Footnotes / references [1] |
Virologic was founded in 1996 by Daniel Capon, Ph.D., Martin Goldstein and Robert S. Capon. The company went public (NASDAQ: VLGC) in 2000.[2]
Monogram was acquired by Laboratory Corporation of America in June 2009.[3]
References
edit- ^ "FORM 10-K".
- ^ SEC. "Monogram Biosciences, Inc. 2000 Quarterly Report 10-Q". SEC.report. p. 10. Retrieved 2020-06-22.
- ^ "LabCorp Successfully Completes Acquisition of Monogram Biosciences, Inc". Business Wire. Retrieved 28 May 2010.
External links
edit- Official website
- Baseline HIV Type 1 Coreceptor Tropism Predicts Disease Progression [1]
- Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay [2]
- Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development [3]
- Trofile Bests SensiTrop as Most Reliable Tropism Test [4]
- Monogram Biosciences teams up with Pfizer for HIV treatment [5]
- Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry) [6]